Dual Diagnosis Capability in Mental Health Treatment (DDCMHT) Toolkit 160
Gotham, H.J., Brown, J.L., Comaty, J., & McGovern,
M.P. (2008). The dual diagnosis capability in
mental health treatment (DDCMHT) index Version
3.2. Kansas City, MO: Mid-American Addiction
Technology Transfer Center.
Grant, B.F., Stinson, F.S., Dawson, D.A., Chou,
S.P., Dufour, M.C., Compton, W., et al. (2004).
Prevalence and co-occurrence of substance use
disorders and independent mood and anxiety
disorders: Results from the national epidemiologic
survey on alcohol and related conditions. Archives
ofGeneral Psychiatry, 61(8), 807-816:
http://archpsyc.ama-assn.org/cgi/reprint/61/8/807.
Hien, D.A., Cohen, L.R., Miele, G.M., Litt, L.C.,
& Capstick, C. (2004). Promising treatments for
women with comorbid PTSD and substance use
disorders. The American Journal of Psychiatry,
161(8), 1426-1432.
Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson,
C.B., et al. (1994). Lifetime and 12-month
prevalence of DSM-III-R psychiatric disorders in the
United States: Result from the National Comorbity
Study. Archives of General Psychiatry, 51(1), 8-19.
Kessler, R.C., Crum, R.M., Warner, L.A., Nelson,
C.B., et al. (1997). Lifetime co-occurrence of DSM-
III-R alcohol abuse and dependence with other
psychiatric disorders in the National Comorbidity
Survey. Archives of General Psychiatry, 54(4),
313-321.
Lee, N., & Cameron, J. (2009). Difference in self
and independent ratings on an organizational dual
diagnosis capacity measure. Drug and Alcohol
Review, 28, 682-684.
Lehman, W.E.K., Greener, J. M., & Simpson, D.D.
(2002). Assessing organizational readiness for
change. Journal of Substance Abuse Treatment,
22(4), 197-209.
Mangrum, L.F., Spence, R.T., & Lopez, M. (2006).
Integrated versus parallel treatment of co-occurring
psychiatric and substance use disorders. Journal
ofSubstance Abuse Treatment, 30(1), 79-84.
Mangrum, L.F. (2007, October 17). Dual diagnosis
capability in addiction treatment: A comparison of
client characteristics and treatment outcomes. Paper
presented at the Addiction Health Services Research
Annual Conference, Athens, GA.
Matthews, H., Kelly, P.J., & Deane, F.P. (2011).
Thedual diagnosis capability of residential addiction
treatment centres: Priorities and condence to
improve capability following a review process.
Drugand Alcohol Review, 30, 195-199.
McEvoy, P.M., & Nathan, P. (2007). Effectiveness
of cognitive behavioral therapy for diagnostically
heterogeneous groups. Journal of Consulting and
Clinical Psychology, 75, 344-350.
McGovern, M.P., & Carroll, K.M. (2003).
Evidence-based practices for substance use
disorders.Psychiatric Clinics of North America,
26(4), 991-1010
McGovern, M.P., Xie, H., Segal, S.R., Siembab, L.,
& Drake, R.E. (2006). Addiction treatment services
and co-occurring disorders: Prevalence estimates,
treatment practices, and barriers. Journal of
Substance Abuse Treatment, 31(3), 267-275.
McGovern, M.P., Matzkin, A.L., & Giard, J. (2007).
Assessing the dual diagnosis capability of addiction
treatment services: The dual diagnosis capability in
addiction treatment (DDCAT) index. Journal of Dual
Diagnosis, 3(2), 111 - 123.
McGovern, M.P., & Giard, J. (2007, October
17). Services research on co-occurring disorders:
Applications of the dual diagnosis capability in
addiction treatment (DDCAT) index. Paper presented
at the Addiction Health Services Research Annual
Conference, Athens, GA.